575 related articles for article (PubMed ID: 29978619)
1. Pathologically Confirmed Cerebral Amyloid Angiopathy with No Radiological Sign in a Patient with Early Onset Alzheimer's Disease.
Kim SJ; Seo Y; Kim HJ; Na DL; Seo SW; Kim Y; Suh YL
Yonsei Med J; 2018 Aug; 59(6):801-805. PubMed ID: 29978619
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
3. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
4. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
5. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
6. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
8. Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
Nagaraja N; Wang WE; Duara R; DeKosky ST; Vaillancourt D
J Alzheimers Dis; 2023; 93(2):495-507. PubMed ID: 37038809
[TBL] [Abstract][Full Text] [Related]
9. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
10. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
11. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.
Thal DR; Papassotiropoulos A; Saido TC; Griffin WS; Mrak RE; Kölsch H; Del Tredici K; Attems J; Ghebremedhin E
Acta Neuropathol; 2010 Aug; 120(2):169-83. PubMed ID: 20535486
[TBL] [Abstract][Full Text] [Related]
12. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
[TBL] [Abstract][Full Text] [Related]
13. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
16. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
17. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A
Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843
[TBL] [Abstract][Full Text] [Related]
18. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
Hecht M; Krämer LM; von Arnim CAF; Otto M; Thal DR
Acta Neuropathol; 2018 May; 135(5):681-694. PubMed ID: 29574591
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
[TBL] [Abstract][Full Text] [Related]
20. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]